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PAX2/5/8 targets <p>A novel bioinformatics pipeline is used to discover PAX2/5/8 direct downstream targets involved in inner ear development.</p>
Abstract
Background: The pax2/5/8 genes belonging to the PAX family of transcription factors are key
developmental regulators that are involved in the patterning of various embryonic tissues. More
particularly, their function in inner ear specification has been widely described. However, little is
known about the direct downstream targets and, so far, no global approaches have been performed
to identify these target genes in this particular tissue.
Results: Here we present an original bioinformatics pipeline composed of comparative genomics,
database querying and text mining tools, which is designed to rapidly and specifically discover
PAX2/5/8 direct downstream targets involved in inner ear development. We provide evidence
supported by experimental validation in medaka fish that brain 2 (POU domain, class 3, transcription
factor 2), claudin-7, secretory pathway component sec31-like and meteorin-like precursor are novel direct
downstream targets of PAX2/5/8.
Conclusions: This study illustrates the power of extensive mining of public data repositories using
bioinformatics methods to provide answers for a specific biological question. It furthermore
demonstrates how the usage of such a combinatorial approach is advantageous for the biologist in
terms of experimentation time and costs.
Background
The pax genes encode a family of transcription factors that
have been conserved through evolution and play different
roles in early development. This family is defined by the pres-
ence of a highly conserved motif of 128 amino acids, the
paired-domain, which does not have any obvious sequence
homology with other known protein domains. Nine members
of the pax  g e n e  f a m i l y  h a v e  b e e n  i s o l a t e d  i n  v e r t e b r a t e s ,
which are grouped into four distinct subfamilies, based on
sequence similarity and structural domains [1-3]. The sub-
family consisting of PAX2, PAX5 and PAX8 (PAX2/5/8)
encodes transcription regulators that bind DNA via the
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amino-terminal paired-domain, whereas the carboxy-termi-
nal region is required for trans-activation or repression of
target genes. Detailed DNA binding studies led to the defini-
tion of a consensus recognition sequence that is bound by all
members of this subfamily [4,5]. The pax2/5/8  genes are
expressed in a spatially and temporally overlapping manner
in the brain, eye, kidney and inner ear in several model organ-
isms [6-9]. Particularly, the members of this subfamily are
the earliest known genes that are involved in inner ear devel-
opment. In teleosts, pax8 is expressed in preotic cells by the
early somitogenesis stages, followed by pax2 expression in
the otic placode and vesicle, whereas pax5 is restricted to the
utricular macula [10-12]. Although the roles of pax2/5/8
genes during ear development are partly illustrated by loss-
of-function, mutant analysis and gain-of-function in fish
[11,13-17], little is known about the direct downstream target
genes of this PAX subfamily. More particularly, although
gene expression profiling comparing wild type and PAX2
mutants has already been performed in mouse embryos [18],
this analysis was restricted to the identification of PAX2 tar-
gets in the midbrain-hindbrain boundary. A systematic dis-
covery of specific PAX2/5/8 direct targets in the otic vesicle
has not yet been performed.
We therefore aimed to identify PAX2/5/8 direct downstream
targets, especially those involved in inner ear development.
For this purpose, we opted for a novel approach that takes
advantage of the vast amount of biological resources gener-
ated by large-scale experiments and available to the scientific
community through public databases. Indeed, on one hand,
numerous high-throughput gene expression pattern screens
(for example, in vertebrates [19-23]) combined with massive
whole-genome sequencing (for example, pioneer efforts with
mammals [24-26]) have generated an invaluable resource of
information concerning any given gene. On the other hand, a
myriad of bioinformatics tools from functional to compara-
tive genomics [27,28] have emerged to extract and mine this
information in a systematic way. Therefore, we took advan-
tage of these bioinformatics tools to develop a strategy that
combines a comparative genomics algorithm, gene expres-
sion pattern databases queries and text mining.
Firstly, we ran an improved version of the previously
described evolutionary double filtering algorithm (EDF) [29]
on PAX2/5/8 position weight matrices (PWMs) [4,5] to pre-
dict PAX2/5/8 downstream targets in silico. This algorithm
has been successfully applied for the discovery of ATH5 target
genes [29] and its power lies in the requirement of a unique
single input, the PWM representing the binding site of the
transcription factor of interest.
Secondly, from this primary list of in silico predicted PAX2/
5/8 target genes, we extracted the subset of candidate genes
that would be specifically involved in otic vesicle development
by selecting the genes that were either known to be expressed
in the otic vesicle or cited in the context of otic vesicle devel-
opment. Queries against mouse and zebrafish expression pat-
tern databases and text mining of MEDLINE abstracts were
respectively applied to perform this selection.
Thirdly, to validate the putative PAX2/5/8 downstream tar-
gets in the otic vesicle predicted by this combination of in sil-
ico analysis, we carried out in vitro electrophoretic mobility
shift assays and in vivo misexpression experiments in
medaka to provide experimental evidence that four predicted
candidates genes (brn2  (pou3f2),  claudin-7,  sec31-like,
ccdc102a and meteorin-like precursor) are new PAX2/5/8
direct target genes for otic development.
Results and discussion
Evolutionary double filtering
The primary list of PAX2/5/8 putative downstream targets
was obtained in silico, by applying an improved version of the
EDF algorithm as described in Del Bene et al. [29] (see also
Materials and methods). This algorithm requires as input the
PWM representing the binding site of the transcription factor
of interest. It delivers as output a list of human genes that
contain the transcription factor binding site in their promoter
region, in a position that is evolutionarily conserved at least
within the mammalian orthologues and, in some cases, up to
other distant vertebrate orthologues (namely fish). Using
binding site conservation as a filter is particularly suitable for
the discovery of PAX2/5/8 downstream targets since the role
of this transcription factor family in the development of the
otic vesicle is conserved throughout vertebrate species [30].
Two different PAX2/5/8 PWMs were used in parallel as input
to the EDF pipeline. The first matrix (matrix A; Figure 1a) was
derived from the TRANSFAC database [31], the second
matrix (matrix B; Figure 1a) was derived from the work of
Czerny and Busslinger [4].
Evolutionarily conserved non-coding DNA sequences, which
are at least 85% similar to these matrices, were retrieved,
resulting in a final list of 672 candidate PAX2/5/8 down-
stream targets genes (Figure 1b; 486 and 195 candidates
using matrices A and B, respectively (Additional data file 1)).
The high number of candidate genes not only reflects the dif-
ferent functions of PAX transcription factors in the different
tissues, but is also a consequence of the high variability of the
PAX2/5/8 consensus binding site (Figure 1b). Hence, previ-
ously known PAX2 direct targets such as pax2 itself or foxi1
[13,14] were recovered by the EDF pipeline when the thresh-
old for matrix similarity was lowered to 80% (data not
shown).
Furthermore, the overlap between the outputs from the two
matrices is fairly small (nine genes), which can be explained
by the differences between the two matrices (compared in
Figure 1a). Indeed, it has been shown that PAX proteins do
not recognize a single consensus DNA-binding sequence [4];http://genomebiology.com/2008/9/10/R145 Genome Biology 2008,     Volume 9, Issue 10, Article R145       Ramialison et al. R145.3
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Figure 1
Combinatorial use of bioinformatics tools and experimental validation. (a) PAX2/5/8 position weight matrices used as input to the pipeline. (b) Workflow 
representing the different steps of the pipeline. The number of genes analyzed after a given step are highlighted in purple.
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therefore, it is expected that the PWMs derived from two dif-
ferent methods are not alike. This ambiguity is not the result
of the differences in nucleotide binding specificities between
different PAX proteins, but rather the inherent flexibility in
the target preference exhibited by PAX proteins. The paired-
domain is highly conserved between all nine PAX ortho-
logues; however, small differences in the paired-domain are
responsible for subfamily specific differences in nucleotide
recognition. For instance, PAX6 and PAX5 proteins, which
are members of two distinct subfamilies, differ in the DNA-
binding specificities of their paired domains by three amino
acid residues [32]. Therefore, running the EDF pipeline using
these two different matrices in parallel provides an advantage
to optimize the discovery of PAX2 target genes.
In order to assess whether this list of putative PAX2/5/8
downstream target genes possesses a bias towards a particu-
lar biological process or molecular function, we analyzed the
Gene Ontology (GO) annotations [33] to calculate over-repre-
sented GO terms. Four terms were significantly enriched
(Figure 2), which can be summarized in two subgroups:
'developmental process' (p-value = 2.11E-06), for the biologi-
cal process category; and 'transcription repressor activity' (p-
value = 1.71E-05) for the molecular function category. These
results are in agreement with PAX2/5/8's well known func-
tion as a developmental transcriptional regulator [34-36],
thereby providing a preliminary validation for the in silico
prediction of target genes.
Identification of candidate genes expressed in the otic 
vesicle
We then sought to further restrict the list of predicted PAX2/
5/8 downstream candidates to those that have a function in
the otic vesicle development. As it is generally acknowledged
that gene co-localization can imply gene co-regulation, we
hypothesized that, if a gene is expressed in the otic vesicle, or
furthermore if it is co-localized with pax2/5/8, it is functional
in this tissue and is more likely to be regulated by PAX2/5/8.
We systematically screened the mouse (GXD) [37] and
zebrafish (ZFIN) [38] expression pattern databases to select
those candidate genes from the primary list of 672 candidate
genes that are known to be expressed in the otic vesicle (Fig-
ure 1b). We chose these two databases since, in terms of
expression pattern annotation, they are the most populated
vertebrate species databases. The combined results from
these databases indicate that amongst the 672 candidate
genes, 392 genes are described in at least one of the databases
(Table 1). Out of these 392 genes, 83 are annotated as
expressed in the otic vesicle (Additional data file 2). A Chi-
square test demonstrates that the list of in silico predicted
target genes is significantly enriched in genes expressed in the
otic vesicle when statistically compared with the total number
of genes described in the otic vesicle in the two databases (p-
value = 0.03).
In parallel, we screened the literature by text mining to select
amongst the 672 putative target genes those that were already
Over-represented Gene Ontology terms in the in silico predicted PAX2/5/8 downstream targets Figure 2
Over-represented Gene Ontology terms in the in silico predicted PAX2/5/8 downstream targets. The x-axis represents the number of genes. The Y-axis 
represents over-represented Gene Ontology categories; corresponding significant p-values are indicated.
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cited in a MEDLINE abstract along with the keywords 'ear',
'otic placode' or 'otic vesicle' (Figure 1b). The search was per-
formed by searching the co-occurrences of the UNIPROT
terms of the candidate genes and one or more of the key-
words. Out of the 438 candidate genes that were described by
a UNIPROT term, 68 co-occurred with the given keywords
(Figure 1b; Additional data file 2). This occurrence is highly
statistically significant when compared to the total number of
genes cited in MEDLINE with these keywords (p-value = 2e-
11).
In total, 133 non-redundant PAX2/5/8 downstream targets
involved in inner ear development were predicted using both
methods and both matrices (Figure 1b). Strikingly, only three
genes were common to both the database and literature
search, while only four genes were annotated in both GXD
and ZFIN databases (Additional data file 2). This number of
overlapping genes demonstrates the complementarity of the
resources and illustrates the benefit we gain from running the
analysis on different bioinformatics datasets.
Experimental validation
In order to experimentally validate the predicted targets, we
chose the vertebrate model system medaka to perform these
experiments, as the comparison of data from three different
vertebrate model organisms (mouse, zebrafish and medaka)
would confer a further line of evidence to the validation of the
in silico process. Indeed, sequence conservation of PAX2/5/8
binding sites amongst different vertebrate species is used as a
positive read-out of functionality in the EDF pipeline. Thus, if
the candidate genes that bear a conserved PAX2/5/8 binding
site in their promoters also display conserved expression pat-
terns (that is, expressed in the otic vesicle) throughout differ-
ent species, they are more likely to be under evolutionary
pressure to maintain functional regulation by PAX2/5/8.
Co-expression verification
Of the 133 PAX2/5/8 putative targets in the otic vesicle, we
searched for medaka orthologues in the Medaka Expression
Pattern Database [39] or in our in-house library of full-length
cDNA clones. Fourteen genes with unambiguous matches
were retrieved at the time of the analysis. This outcome was
equivalent to a random selection from the 133 putative targets
as these 14 genes consist of candidates predicted from both
PAX2/5/8 matrices and from database and literature screen-
ing (Table 2; Additional data file 2). Whole mount in situ
hybridization was performed at different stages of otic devel-
opment from otic placode stage (4 somite stage) to inner ear
stage (four day old embryos).
We observed that 8 out of the 14 candidate genes tested exhib-
ited a specific expression in the otic vesicle region, with at
least partially overlapping expression with either the pax8 or
pax2 gene during otic development (compare Figure 3a and
3b; Additional data file 3): coiled-coil domain-containing
protein 102A (ccdc102a),  meteorin-like protein precursor
(mtrnl),  sec31-like isoform 1 (sec31l),  claudin-7  (cldn7),
brain-specific homeobox/POU domain protein 2 (brn2/
pou3f2) (Figure 3b), claudin-4 (cldn4), ionized calcium-bind-
ing adapter molecule 2 (iba2) and brain mitochondrial car-
rier protein-1 (bmcp1) (Additional data file 3). It is
interesting to note here that bmcp1 is described as expressed
in the otic vesicle neither in GXD nor in ZFIN gene expression
pattern databases, whereas it has been reported in the litera-
ture only to be localized in rat and mouse inner ears [40]. This
particular example illustrates the beneficial contribution of
text mining queries in the pipeline. One candidate, XTP3-
transactivated gene B protein precursor (erlectin), exhibited
a weaker expression pattern in the otic vesicle (Additional
data file 3) when compared to the former eight strongly and
specifically expressed genes.
In total, 9 out of 14 candidates showed a specific expression in
the otic vesicle, demonstrating the power of the in silico
approach to predict otic vesicle markers. The remaining five
candidates either exhibited an expression pattern in the otic
vesicle scarcely distinguishable from a strong ubiquitous
staining all over the embryo (lysosome-associated mem-
brane glycoprotein 1 precursor (lamp1), major vault protein
(mvp); data not shown), or they were not expressed at all in
the otic vesicle (basic helix-loop-helix domain containing,
class B, 5 (bhlhb5), skeletal muscle LIM-protein 1 (slim1),
Table 1
Occurrences of PAX2/5/8 candidate target genes predicted from matrices A and B in mouse (GXD) and zebrafish (ZFIN) databases
Matrix A Matrix B Matrices A+B Total genes
Candidate genes 486 195 672 22,242
Genes described in GXD 209 96 301 7,080
Genes described in ZFIN 135 55 188 5,623
Genes described in GXD and ZFIN 274 122 392 10,082
Genes expressed in ear in GXD 52 14 66 1,267
Genes expressed in ear in ZFIN 18 6 24 5,72
Genes expressed in ear in GXD and ZFIN 64 19 83 1,717
Numbers in bold are the values used to construct the contingency table, used for the calculation of the over-representation of genes expressed in 
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epidermal growth factor receptor substrate 15-like 1
(eps15rl1)).
Functional assays
To gain further insight into the interaction between PAX2/5/
8 and these nine downstream candidates specifically
expressed in the otic vesicle, pax2  overexpression experi-
ments were undertaken. To overcome potential unspecific
effects caused by morphological alterations through misex-
pression of pax2 at earlier stages, we decided to use the artifi-
cial heat shock promoter HSE and the meganuclease injection
technique [41,42], which results in broad misexpression in
the majority of medaka embryos.
Four of the nine candidate genes (cldn7, ccdc102a, mtrnl and
sec31l) exhibited ectopic expression in the otic region in the
pax2 misexpressing embryos (Figure 3c and Table 3). One
candidate, brn2, was significantly repressed upon pax8 over-
expression (Figure 3c and Table 3). Interestingly, another
BRN homologue (brn1) has already been identified as a direct
PAX2 downstream target in the specification of the mid-hind-
brain boundary in mouse embryos [18]. However, it seems
that members of PAX2/5/8 protein influence the expression
of brn genes differently. While in the mid-hindbrain bound-
ary region PAX2 activates brn1, in the otic vesicle Pax8
represses  brn2  expression; presumably, the interaction of
Pax2/8 proteins with co-repressor factors like Groucho pro-
teins in the otic vesicle leads to repression of the brn2 gene.
To exclude unspecific false positive results, we selected three
genes annotated to be expressed in the otic vesicle in the
expression pattern databases, but that are not present in the
PAX2/5/8 candidate target genes list. We analyzed the
expression of these three clones in misexpressing pax2
embryos. All three genes showed no specific ectopic expres-
sion in the otic vesicle region (Additional data file 4). Further-
more, it has already been shown that four other genes (six1,
eya1, otx1 and gbx2) co-expressed with Pax2/8 but absent
from the candidate target genes list do not show altered
expression upon Pax2 over-expression [14], supporting the
specificity of our assay.
In total, the expression patterns of five out of nine genes
tested were altered upon Pax2/8 misexpression. With the
knowledge from the EDF pipeline that these five genes con-
tain a conserved PAX2/5/8 binding site in their promoter
region, we tested the ability of Pax2 to directly bind to these
sites. Electrophoretic mobility shift assays were performed on
40 bp oligos containing the predicted PAX2/5/8 binding site
for each gene (Figure 4a). The experiment shows that Pax2
directly interacts with four of the five candidate genes (brn2,
mtrnl, cldn7 and sec31l; Figure 4b). Competition assays using
non-labeled oligonucleotides confirm the specificity of the
Table 2
Candidate genes selected for experimental validation
Gene Human EnsEMBL ID GXD ZFIN TM Matrix
Clones specifically expressed in otic vesicle and Pax2 responsive
Mtrnl ENSG00000176845 √ B
ccdc102a ENSG00000135736 √ B
sec31l ENSG00000138674 √ A
cldn7 ENSG00000181885 √ A
brn2 ENSG00000184486 √ A
Clones specifically expressed in otic vesicle
iba1 ENSG00000126878 √√ B
erlectin ENSG00000068912 √ A
cldn4 ENSG00000189143 √ B
Bmcp1 ENSG00000102078 √ A
Clones ubiquitously expressed
lamp1 ENSG00000185896 √ A
Clones not expressed in otic vesicle
bhlhb5 ENSG00000180828 √ B
mvp ENSG00000013364 √√ A
slim1 ENSG00000022267 √ B
eps15l1 ENSG00000127527 √ Ahttp://genomebiology.com/2008/9/10/R145 Genome Biology 2008,     Volume 9, Issue 10, Article R145       Ramialison et al. R145.7
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binding. Furthermore, we introduced three point mutations
in the most conserved nucleotide positions of the PAX2/5/8
binding site (in the context of cldn7; Figure 4a). Electro-
phoretic mobility shift assay on this oligonucleotide revealed
that the Pax2 binding was abolished, further validating that
the Pax2-DNA interaction is specifically occurring through
these predicted binding sites.
Therefore, these experimental results demonstrate that brn2,
mtrnl, cldn7 and sec31l are direct targets of PAX2/5/8 tran-
scription factors.
Conclusions
The large costs of genome sequencing efforts and high-
throughput approaches are justified by the wealth of biologi-
cal information they eventually provide to the scientific com-
munity. It is worthwhile, therefore, to exploit these resources,
which are mostly freely available, in order to quickly provide
data to the biologist for further experimental studies.
In this study, we have demonstrated that taking advantage of
available bioinformatics techniques, from comparative
genomics to database and text mining, efficiently and rapidly
identifies new direct downstream targets of the PAX2/5/8
transcription factor family. This pipeline also allowed the dis-
Genes specifically expressed in the otic vesicle that are responsive to Pax2/8 over-expression Figure 3
Genes specifically expressed in the otic vesicle that are responsive to Pax2/8 over-expression. Lateral views of medaka embryos. Anterior is towards the 
left. Developmental stages (Stg) are indicated for each embryo. (a, b) Normal expression patterns of pax2/5/8 genes (a), and pax2/5/8 target candidates 
(b) during otic vesicle development. The ccdc102a transcript is absent in the otic vesicle until stage 29; at this stage it was detected in the medioventral 
part of the otic vesicle (dashed line). The metrnl transcript could be found weakly at stage 32 (dashed line), whereas sec31l mRNA was detected from early 
otic vesicle development in the epithelium and later in the medial part of the otic vesicle. The cldn7 gene exhibits a broad expression during otic 
development from the otic placode stage (data not shown) till stage 33 where the expression is restricted to the medial cristae. brn2 expression is 
restricted to the medial part of the otic vesicle. (c) Overexpression of pax2 and pax8 leads to ectopic (all except for brn2) expression or repression (brn2) 
of the candidate genes. At stage 24, ccdc102a is overexpressed in the dorsal epithelium (arrows).
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covery of previously undescribed novel otic vesicle specific
genes, which are amenable to further functional analysis.
Although the number of targets discovered with this
approach is not comparable to that of 'wet' experimental tech-
niques, such as large-scale chromatin-immunoprecipitation
[43], this pipeline offers the major advantages of delivering
results after a run time of just a day, being applicable to other
transcription factors and identifying key downstream targets
using sequence and expression conservation.
We have demonstrated that an alternative approach combin-
ing simple straightforward bioinformatics pipelines can help
the biologist to target their questions and obtain encouraging
results, in a fast and cost-efficient way.
Materials and methods
Bioinformatics pipeline
Evolutionary double filtering
We improved the EDF pipeline described in [29] to take
Table 3
Pax2/8 over-expression effect on predicted downstream targets
Clone Expression in the otic vesicle Effect upon pax2 misexpression (%)* n
brn2 Yes Repression: 40 28
ccdc102a Yes Activation: 23 34
metrnl Yes Activation: 35 20
sec31l Yes Activation: 44 25
cldn7 Yes Activation: 28 51
*Injected embryos were heat treated during nine somites. Three hours later, GFP positive embryos were fixed.
Direct interaction with Pax2 and predicted target genes Figure 4
Direct interaction with Pax2 and predicted target genes. (a) Oligonucleotide sequences of the predicted target genes containing the PAX2/5/8 binding site. 
The consensus sequence is indicated in the top row in IUPAC code. Within this binding site, conserved base pairs between all the targets are highlighted 
in dark blue, and conserved base pairs in at least three targets genes are highlighted in light blue. The three point mutations in the PAX2/5/8 binding site of 
cldn7 are indicated in red. (b) Binding ability of Pax2 on the promoters of brn2, metrnl, sec31l and cldn7 in the presence of increasing concentrations of cold 
competitor. First lane: oligonucleotide only. Second lane: oligonucleotide + Pax2. Third lane: oligonucleotide + Pax2 + 100× cold competitor. Fourth lane: 
oligonucleotide + Pax2 + 500× cold competitor.
 
 
 
 
c
l
d
n
7
c
l
d
n
7
s
e
c
3
1
l
m
e
t
r
n
l
b
r
n
2
competitor
Pax2  -     +    +    +  -     +    +    +  -     +    +    +  -     +    +    +  -     +    +    +
PAX2/5/8 consensus          RVDCASTGARGSKTDWM
brn2     AACTGCCATGTGCGCAGTGAAGGGTTAATCAGATCAATAGACTGA
metrnl     GAACAGAAATAACACACTGAAGCTTGTCCCAGATGACCCAAATTC
sec31l     AGCTGGTAGAAGGTCACTGAAGCTTAAATACAGGTTTTCCAATTC
cldn7     TAGGGAGGACGGAACAGTGAGGCGTGACAGAGTGCACAGCAATTG
Δcldn7     TAGGGAGGACGGAAAAGTGAGTCGAGACAGAGTGCACAGCAATTG
(b)
(a)http://genomebiology.com/2008/9/10/R145 Genome Biology 2008,     Volume 9, Issue 10, Article R145       Ramialison et al. R145.9
Genome Biology 2008, 9:R145
advantage of the increased number of vertebrate genomes
sequenced since it was first published. The 4 kilobase
upstream sequences of orthologues in the following species
were retrieved from EnsEMBL compara v29: Homo sapiens,
Pan troglodytes, Mus musculus, Rattus norvegicus, Canis
familiaris,  Gallus gallus,  Xenopus tropicalis,  Tetraodon
nigroviridis, Fugu rubripes and Danio rerio.
The PWM, which was given as input, was matched to all
sequences, in an alignment independent manner. In order to
increase the weight between matches on distantly related
sequences, for all sequences that matched the PWM at least
once, the distance measures to all the other matching
sequences were calculated using a previously published met-
ric [44] (tuple size = 5). The matching sequence was then
weighted with the distance to the nearest sequence (for exam-
ple, if two sequences are identical, then one sequence will be
weighted 0) and all the weights were added in order to get a
final score. All genes with a final score above 1 were
considered.
As input to the EDF pipeline, two different PAX2/5/8 PWMs
were processed in parallel. the first PWM, matrix A (Figure
1a), was derived from the TRANSFAC database [31] based on
in vitro selection data obtained from Epstein et al. [5]. The
second PWM, matrix B (Figure 1b), was derived from the
work of Czerny at al. [4] based on a compilation of known
PAX binding sites. Matches to the PAX2/5/8 PWM with more
than 85% identity were selected. The graphical output of
these matrices (Figure 1a) was generated using the WebLogo
program [45].
Gene Ontology over-representation
Over-representation of GO terms was calculated using
Fisher's exact test of statistical significance, implemented in
the G:profiler software [46], providing as input the primary
list of 672 in silico predicted target genes.
Database queries
GXD
The total list of genes described in GXD was obtained from
database dumps (April 2006, updated on March 2008) from
the GXD Data and Statistical Reports in the 'gene expression'
section. The list of genes expressed in the otic vesicle and sub-
structures was directly downloaded from the Mouse Genome
Informatics website [37] using the Gene Expression Data
Query Form. Default parameters were used except for
'Expression = detected', 'Anatomical Structure(s) = ear' and
'Sorting and output format = no limit'.
ZFIN
The total list of genes described in ZFIN was obtained from
querying the web interface for genes expressed in 'ear', 'otic
placode', 'otic vesicle' and substructures (April 2006). Data
update was performed on March 2008, using the database
dumps for 'gene expression'. Perl scripts were written to
select only the genes described by in situ hybridization in a
wild-type background. The subset of genes expressed in the
otic vesicle were obtained by selecting from the total list of
described genes those which have been annotated to be
expressed in the otic vesicle and its substructures. The list of
otic vesicle substructures was obtained from the Ontology
Lookup Service [47], using 'otic placode' as input.
We applied a Chi-square test to calculate the over-representa-
tion of genes annotated in the otic vesicle in the predicted list
of PAX2/5/8 candidates, compared to the total occurrences
of genes annotated to be expressed in the otic vesicle in GXD
and ZFIN. Values used for the contingency table are high-
lighted in Table 1.
MEDLINE
Computer-assisted text mining [48] was employed to select
MEDLINE abstracts containing at least one name or syno-
nym listed in the UNIPROT entries of the candidate genes
and at least one of the following keywords: 'ear', 'otic vesicle'
and 'otic placode' (according to MEDLINE contents on
August 2005 and March 2008). To assess the significance of
the co-occurrence of candidate genes with these terms, we
used computer cluster farms to calculate the total number of
genes cited in MEDLINE (using UNIPROT terms), and the
fraction of genes cited with the given keywords. In total,
14,453 UNIPROT terms where found in more than 15 million
MEDLINE abstracts, amongst which 1,047 were cited with
the keywords. These values were used to populate the contin-
gency table for the Chi-square test in order to calculate the
corresponding p-value.
Experimental validation
Fish strain and maintenance
Embryos of the medaka Cab inbred strain [49] were used for
all experiments. Stages were determined according to Iwa-
matsu [50].
Microinjection and heat shock treatment
For experimental validation, the heat-inducible pSGHPax2
and pSGHPax8 constructs were used as described in [14,41].
Medaka embryos were microinjected at 20-40 ng/μl into sin-
gle blastomeres at the one- to two-cell stage. DNA was co-
injected with the I-SceI meganuclease enzyme as described
[42]. After injection the embryos were incubated at 28°C.
Embryos lacking background green fluorescent protein (GFP)
activity were selected prior to heat shock treatment. For all
experiments, the heat treatment was performed for 2 h at
39°C. Four hours after heat shock embryos were fixed for in
situ hybridization analysis.
Whole mount in situ hybridization
The medaka orthologues corresponding to the candidate
genes were obtained using EnsEMBL Biomart [51]. The cor-
responding clones to these genes were blasted (blastn, per-
centage of identity >95%) against the Medaka Expressionhttp://genomebiology.com/2008/9/10/R145 Genome Biology 2008,     Volume 9, Issue 10, Article R145       Ramialison et al. R145.10
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Pattern Database [39] and against an in-house library of
medaka sequenced cDNA clones at the EMBL. In situ hybrid-
ization analysis of the 14 downstream targets selected was
primarily performed using Intavis Robot as previously
described in [19]. For the functional validation, in situ hybrid-
ization was performed three to four hours after heat shock,
GFP positive embryos were fixed over-night in 4% parafor-
maldehyde/2 × PTW (phosphate-buffered saline/Tween).
Whole-mount in situ hybridization was performed at 65°C as
described previously using DIG-labeled probes [52].
Electrophoretic mobility shift assay
Double stranded oligonucleotides for each candidate gene
were designed to contain the predicted PAX2/5/8 binding
site and flanking regions up to 40 bp and an additional 5'-
GGG overhang for labeling: cldn7  human promoter,
5'gggTAGGGAGGACGGAACAGTGAGGCGTGACAGAGT-
GCACAGCAATTG;  sec31l  human promoter,
5'gggAGCTGGTAGAAGGTCACTGAAGCTTAAATACAG-
GTTTTCCAATTC;  brn2 Xenopus tropicalis promoter,
5'gggAACTGCCATGTGCGCAGTGAAGGGTTAATCAGAT-
CAATAGACTGA;  metrnl  zebrafish promoter,
5'gggGAACAGAAATAACACACTGAAGCTTGTCCCAGAT-
GACCCAAATTC;  ccdc102a  human promoter,
5'gggATTCACCTCGGGGGCCTTCCAGGGTACAGGATG-
TAGTGGGGAGTC;  Δcldn7  human promoter,
5'gggTAGGGAGGACGGAAAAGTGAGTCGAGACAGAGTGC
ACAGCAATTG.
Complementary oligonucleotides were annealed and end-
labeled with Klenow DNA polymerase and [α-32P]dCTP. Cor-
responding cold probes where processed in parallel using
non-labeled dCTP for competition assays. Zebrafish pax2 was
in vitro translated using the Promega TnT sp6/T7 coupled
reticulocyte lysate system according to manufacturer's
instructions. One fmole of labeled DNA probe was incubated
with 5 μl of Pax2 translation reaction for 30 minutes at room
temperature in the following binding buffer: 100 mM KCl, 10
mM Hepes (pH 8), 1 mM DTT, 5% glycerol, 1 mM EDTA and
1 μg poly(dI:dC) in a total volume of 20 μl in water. Competi-
tion was performed with 100- or 500-fold molar excess of
cold competitor. The DNA-protein complex was resolved on a
native 6% polyacrylamide gel (in 0.5 × TBE) at 160 V at 4°C
for 2 h. The gel was dried and visualized by autoradiography.
Abbreviations
EDF: evolutionary double filtering; EMSA: electrophoretic
mobility shift assay; GFP: green fluorescent protein; GO:
Gene Ontology; PWM: position weight matrix.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a table listing the
candidate genes from the EDF pipeline (matrices A and B).
Additional data file 2 is a table listing Pax2/5/8 putative
downstream targets predicted to be expressed in the otic ves-
icle by systematic queries in mouse (MGI), zebrafish (ZFIN)
databases and MEDLINE abstracts. Additional data file 3 is a
figure representing the genes specifically expressed in the otic
vesicle but not affected by Pax2/8 over-expression. Addi-
tional data file 4 is a table listing the negative candidate genes
for the validation of the pax2 over-expression system.
Additional data file 1 Candidate genes from the EDF pipeline (matrices A and B) Candidate genes from the EDF pipeline (matrices A and B). Click here for file Additional data file 2 Pax2/5/8 putative downstream targets predicted to be expressed in  the otic vesicle by systematic queries in mouse (MGI), zebrafish  (ZFIN) databases and MEDLINE abstracts The genes highlighted in color are those that were subjected to  experimental validation in medaka. Green: genes specifically  expressed in the otic vesicle and affected by Pax2/8 overexpression  (see also Figure 3). Blue: genes expressed in the otic vesicle but not  affected by Pax2/8 overexpression (see also Additional data file 3).  Pink: genes not expressed in the otic vesicle. Click here for file Additional data file 3 Genes specifically expressed in the otic vesicle but not affected by  Pax2/8 over-expression Dorso-lateral views of medaka otic vesicle, anterior is towards the  left. Developmental stages (Stg) are indicated for each embryo. All  four candidates exhibit a weak expression in the otic epithelium. Click here for file Additional data file 4 Negative candidate genes for the validation of the pax2 over- expression system l2hgdh: L-2-hydroxyglutarate dehydrogenase, mitochondrial pre- cursor, c22orf28: unknown protein, tacstd2: tumor-associated cal- cium signal transducer 2 precursor. Click here for file
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